CLDWW
Calidi Biotherapeutics, Inc.
NYSE Biological Products, (No Diagnostic Substances)
Emerging growth company

Key Financials

Revenue
$45000
N/A
Net Income
$-19906000
↑ 10.1%
Operating Income
$-20240000
↑ 7.1%
Total Assets
$8.9M
↓ 37.5%
EPS (Diluted)
$-5.95
↓ 100.3%
Total Liabilities
$5.1M
↓ 58.3%
Cash & Equivalents
$9.6M
↑ 803.4%
Shareholders' Equity
$3.8M
↑ 145.0%

Recent SEC Filings

Form Type Filed Date Link
3 6/29/2026 View on SEC
8-K 6/23/2026 View on SEC
8-K 6/18/2026 View on SEC
DEFA14A 6/5/2026 View on SEC
8-K 5/29/2026 View on SEC
SCHEDULE 13G 5/15/2026 View on SEC
10-Q 5/14/2026 View on SEC
8-K 5/14/2026 View on SEC
8-K 5/8/2026 View on SEC
DEFA14A 4/29/2026 View on SEC

Company Information

Field Value
Ticker CLDWW
Company Name Calidi Biotherapeutics, Inc.
CIK 1855485
Sector Biological Products, (No Diagnostic Substances)
Industry
Emerging growth company
Exchange NYSE
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 858-794-9600